In agreement with our results, a meta-analysis suggested that ABCB1 c.1236CT polymorphism is a risk factor for non-optimal clinical response in Asian CML patients[21]. The gene discussed is ABCB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.